Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIONEER pre-operative letrozole plus megestrol acetate versus letrozole alone in ER-positive breast cancer
2016-003752-79Phase 2Unknown
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole, megestrol in breast cancer, sponsored by Cambridge University Hospitals NHS Foundation Trust. Status: unknown.
02
Drugs
letrozolemegestrol
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-003752-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003752-79.